Thermo Fisher Scientific | TMO - Operating Profit


Thermo Fisher Scientific reported $1.91B in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
Abbott USD 1.85B 399M Mar/2026
Agilent USD 399M 46M Mar/2026
Becton, Dickinson and Co. USD 627M 36M Mar/2026
Bio Techne USD 75.49M 21.03M Mar/2026
Bio-Rad Laboratories USD 53.9M 10M Dec/2025
Boston Scientific USD 1.05B 190M Mar/2026
Bruker USD 10.2M 66.1M Mar/2026
Charles River Laboratories USD 119.9M 44.08M Mar/2026
Danaher USD 1.34B 158M Mar/2026
Dentsply International USD 32M 506M Mar/2026
Edwards Lifesciences USD 514.7M 144.4M Mar/2026
General Electric Aerospace USD 2.32B 549M Mar/2026
Henry Schein USD 182M 4M Mar/2026
Illumina USD 239M 17M Mar/2026
Intuitive Surgical USD 859.7M 5.6M Mar/2026
IQVIA Holdings USD 565M 2.11B Mar/2026
Laboratory Of America USD 410.1M 28.1M Mar/2026
Medtronic USD 2.09B 354M Mar/2026
Mettler Toledo International USD 233.93M 118M Mar/2026
Myriad Genetics USD -3M 20.3M Dec/2025
Olympus JPY 26.87B 1.14B Mar/2026
OraSure Technologies USD -13.59M 2.13M Dec/2025
Quest Diagnostics USD 399M 13M Mar/2026
Repligen USD 19.98M 13K Mar/2026
Revvity USD 82.77M 63.06M Mar/2026
Stryker USD 1.1B 867M Mar/2026
Thermo Fisher Scientific USD 1.91B 389M Mar/2026
Veracyte USD 19.08M 5.55M Mar/2026
Waters USD 148M 122.52M Mar/2026
Zimmer Biomet Holdings USD 395.1M 92.2M Mar/2026